Jinyu Bio-Technology Co (SHSE:600201) Cyclically Adjusted FCF per Share: ¥0.22 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600201 Jinyu Bio-Technology Co Ltd SHSE:600201
65 GF Score
Price ¥11.19
GF Value ¥8.36
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Jinyu Bio-Technology Co Cyclically Adjusted FCF per Share?

Jinyu Bio-Technology Co SHSE:600201 -3.20% 65 Cyclically Adjusted FCF per Share is ¥0.22 as of Mar. 2026. GuruFocus rates SHSE:600201 with a GF Score™ of 65/100 and a GF Value™ of ¥8.36 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Jinyu Bio-Technology Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.021. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.22 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jinyu Bio-Technology Co's average Cyclically Adjusted FCF Growth Rate was -12.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -10.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -5.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Jinyu Bio-Technology Co was 74.70% per year. The lowest was -10.40% per year. And the median was 9.80% per year.

As of today (2026-07-25), Jinyu Bio-Technology Co's current stock price is ¥11.19. Jinyu Bio-Technology Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.22. Jinyu Bio-Technology Co's Cyclically Adjusted Price-to-FCF of today is 50.86.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Jinyu Bio-Technology Co was 118.56. The lowest was 21.33. And the median was 65.73.


Jinyu Bio-Technology Co  (SHSE:600201) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Jinyu Bio-Technology Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=11.19/0.22
=50.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Jinyu Bio-Technology Co was 118.56. The lowest was 21.33. And the median was 65.73.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Jinyu Bio-Technology Co Cyclically Adjusted FCF per Share Related Terms


Jinyu Bio-Technology Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Jinyu Bio-Technology Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinyu Bio-Technology Co Cyclically Adjusted FCF per Share Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.32 0.26 0.24 0.23

Jinyu Bio-Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.25 0.25 0.23 0.22

SHSE:600201 vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Jinyu Bio-Technology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinyu Bio-Technology Co Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Jinyu Bio-Technology Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600201
65GF Score
Jinyu Bio-Technology Co Ltd SHSE:600201
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jinyu Bio-Technology Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jinyu Bio-Technology Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.021/116.3033*116.3033
=-0.021

Current CPI (Mar. 2026) = 116.3033.

Jinyu Bio-Technology Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.005 101.400 0.006
201609 0.183 102.400 0.208
201612 0.300 102.600 0.340
201703 0.102 103.200 0.115
201706 0.013 103.100 0.015
201709 0.022 104.100 0.025
201712 0.236 104.500 0.263
201803 -0.040 105.300 -0.044
201806 -0.099 104.900 -0.110
201809 -0.032 106.600 -0.035
201812 0.066 106.500 0.072
201903 -0.128 107.700 -0.138
201906 0.039 107.700 0.042
201909 0.011 109.800 0.012
201912 0.169 111.200 0.177
202003 -0.004 112.300 -0.004
202006 0.013 110.400 0.014
202009 0.192 111.700 0.200
202012 0.221 111.500 0.231
202103 -0.027 112.662 -0.028
202106 -0.046 111.769 -0.048
202109 0.073 112.215 0.076
202112 0.144 113.108 0.148
202203 -0.057 114.335 -0.058
202206 0.010 114.558 0.010
202209 0.131 115.339 0.132
202212 0.072 115.116 0.073
202303 -0.065 115.116 -0.066
202306 0.125 114.558 0.127
202309 0.065 115.339 0.066
202312 0.001 114.781 0.001
202403 0.011 115.227 0.011
202406 0.066 114.781 0.067
202409 0.053 115.785 0.053
202412 0.054 114.893 0.055
202503 0.014 115.116 0.014
202506 0.043 114.907 0.044
202509 0.063 115.471 0.063
202512 0.050 115.832 0.050
202603 -0.021 116.303 -0.021

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.22 mean?
Jinyu Bio-Technology Co (SHSE:600201) has a Cyclically Adjusted FCF per Share of ¥0.22 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Jinyu Bio-Technology Co and its competitors.
Is Jinyu Bio-Technology Co's Cyclically Adjusted FCF per Share too high?
Jinyu Bio-Technology Co's current Cyclically Adjusted FCF per Share is ¥0.22. Overall, Jinyu Bio-Technology Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Jinyu Bio-Technology Co's Cyclically Adjusted FCF per Share of ¥0.22 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Jinyu Bio-Technology Co and its competitors. Jinyu Bio-Technology Co's current Cyclically Adjusted FCF per Share is ¥0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.36, compared to a current price of ¥11.19 — trading 33.9% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.22. Jinyu Bio-Technology Co's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current Cyclically Adjusted FCF per Share is ¥0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?

Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued. The current stock price of ¥11.19 is trading 33.9% above its estimated GF Value™ of ¥8.36. GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600201:

  • Cyclically Adjusted FCF per Share: ¥0.22
  • GF Value™: ¥8.36 vs. price of ¥11.19 (33.9% above fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jinyu Bio-Technology Co Business Description

Address No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
65GF Score

Get the complete analysis for SHSE:600201

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.19
Price
¥8.36
GF Value